NVNO
enVVeno Medical Corp
NASDAQ: NVNO · HEALTHCARE · MEDICAL DEVICES
$10.50
+0.57% today
Updated 2026-05-01
Market cap
$7.81M
P/E ratio
—
P/S ratio
216.91x
EPS (TTM)
$-33.06
Dividend yield
—
52W range
$9 – $197
Volume
0.0M
WallStSmart proprietary scores
29
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →204 stocks currently score above 75
Price targets
Analyst target
$12.50
+19.05%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-3.44M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-24.67M | $-23.52M | $-21.82M | $-19.47M | $-3.74M |
| EPS | — | — | — | — | $-33.06 |
| Free cash flow | $-15.73M | $-18.89M | $-16.88M | $-15.57M | $-3.44M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
enVVeno Medical Corp trades at $10.50. Our Smart Value Score of 29/100 indicates the stock is weak.
Frequently asked questions
What is enVVeno Medical Corp's stock price?
enVVeno Medical Corp (NVNO) trades at $10.50.
Is enVVeno Medical Corp overvalued?
Smart Value Score 29/100 (Grade F, Strong Sell).
What is the price target of enVVeno Medical Corp (NVNO)?
The analyst target price is $12.50, representing +19.0% upside from the current price of $10.50.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio216.91x
ROE-56.20%
Beta1.09
50D MA$11.07
200D MA$38.31
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—